| Patent application number | Description | Published |
|---|
| 20080280929 | Antifungal Wallboards and Building Materials and Methods for the Production Thereof - The present invention relates to, inter alia, methods for the treatment of wallboards and the treated wallboards. In particular, the invention relates to the treatment of wallboards with a fungicidally effective amount of a strobilurin or strobilurin-type fungicide. In a particular embodiment the fungicide is azoxystrobin. The invention also provides for the treatment of wallboards and building materials with combinations of fungicides present in synergistic amounts. | 11-13-2008 |
| 20100016159 | HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF - The present invention relates to a to a method of controlling the growth of weeds, in particular, large crabgrass and white clover, using a herbicidal composition comprising mesotrione and a triazolinone herbicide such as sulfentrazone or carfentrazone-ethyl. The invention also relates to the use of this composition. | 01-21-2010 |
| 20100184596 | METHOD FOR THE CONTROL OF WEEDS IN TURF - The present invention relates to a method for controlling weeds in turfgrass, which comprises applying to the turfgrass, the locus thereof or seeds thereof a herbicidally effective amount of 4-Hydroxy-3-[2-(2-methoxyethoxymethyl)-6-trifluoromethylpyridine-3-carbonyl]-bicyclo[3.2.1]oct-3-en-2-one or a composition which contains said compound. | 07-22-2010 |
| 20100210464 | HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF - The present invention relates to method of controlling the growth of weeds, in particular goosegrass and white clover, using a herbicidal composition comprising mesotrione and pendimethalin. It also relates to the use of this composition. | 08-19-2010 |
| 20100304969 | HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF - The present invention relates to method of controlling the growth of weeds, in particular white clover, using a herbicidal composition comprising mesotrione and oxadiazon. It also relates to the use of this composition. | 12-02-2010 |
| 20110245079 | STABILIZED PESTICIDAL GRANULES - The present invention provides a stabilized pesticidal composition comprising at least one granular substrate material containing at least one metal chelate of 2-(2′-nitro-4′-methylsulphonylbenzoyl)-1,3-cyclohexanedione, a method of producing a stabilized granular pesticidal composition which comprises incorporating a metal chelate of 2-(2′-nitro-4′-methylsulphonylbenzoyl)-1,3-cyclohexanedione in to or on to a granular substrate material; and a method of killing or controlling weeds or unwanted vegetation (without damaging beneficial plants and or seeds) which comprises applying a herbicidally effective amount of the stabilized granular pesticide composition of the invention to the foliage, tissue or locus of the weeds or unwanted vegetation. | 10-06-2011 |
| 20110263425 | HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF - The present invention relates to a method of controlling the growth of weeds, in particular, large crabgrass and white clover, using a herbicidal composition comprising mesotrione and atrazine. | 10-27-2011 |
| Patent application number | Description | Published |
|---|
| 20100028447 | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs - The present invention generally relates to pharmaceutical compositions for the intranasal, buccal, or sublingual administration of metanicotine analogs. | 02-04-2010 |
| 20100247617 | Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)yl)-4-Penten-2-Amine - The present invention generally relates to the transdermal administration of (2S)-(4E)-N-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine, or pharmaceutically acceptable salts thereof. The transdermal administration can be effected using transdermal drug delivery devices, semi-solid dosage forms, or iontophoresis. The drug delivery devices and/or semi-solid dosage forms can provide instantaneous release, sustained release, or combinations thereof, and can include permeation enhancers and other components to assist in drug transport across the dermis, especially the epidermis. The compositions can be used to treat and/or prevent any indication which the active ingredients are capable of treating and preventing, but deliver (2S)-(4E)-N-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine, or pharmaceutically acceptable salts thereof, in an efficacious manner. Disorders that can be treated and/or prevented include central nervous system disorders, addictions, pain, and inflammation. | 09-30-2010 |
| Patent application number | Description | Published |
|---|
| 20080207505 | Bna Conjugates and Methods of Use - Modified natriuretic compounds and conjugates thereof are disclosed in the present invention. In particular, conjugated forms of hBNP are provided that include at least one modifying moiety attached thereto. The modified natriuretic compound conjugates retain activity for stimulating cGMP production, binding to NPR-A receptor, decreasing arterial blood pressure and in some embodiments an improved half-life in circulation as compared to unmodified counterpart natriuretic compounds. Oral, parenteral, enteral, subcutaneous, pulmonary, and intravenous forms of the compounds and conjugates may be prepared as treatments and/or therapies for heart conditions particularly congestive heart failure. Modifying moieties comprising oligomeric structures having a variety of lengths and configurations are also disclosed. Analogs of the hBNP compound are also disclosed, having an amino acid sequence that is other than the native sequence. | 08-28-2008 |
| 20090221485 | ORAL PEPTIDES CONJUGATES FOR METABOLIC DISEASES - The present invention relates to the field of metabolic compound conjugates, methods of forming said conjugates and uses of these conjugates in the treatment of diabetes and conditions related to this condition. The metabolic compound conjugates of this invention include a metabolic peptide having a glucagon-like peptide (GLP-1) receptor binding motif for action on a GLP-1 receptor and at least one oligomer conjugation site for binding with at least one oligomer, wherein the oligomer includes a polyethylene glycol moiety (PEG), and/or alkyl moiety. | 09-03-2009 |
| 20100105605 | FATTY ACID FORMULATIONS AND ORAL DELIVERY OF PROTEINS AND PEPTIDES, AND USES THEREOF - Fatty acid compositions for administration of of pharmaceutical agents, such as proteins and peptides, protein and peptide conjugates, and/or cation-polypeptide conjugate complexes. In particular, the invention provides a solid pharmaceutical composition formulated for oral administration by ingestion, having from about 0.1 to about 75% w/w fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent. Further, the invention provides a liquid pharmaceutical composition formulated for oral administration by ingestion, comprising: from about 0.1 to about 10% w/v fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent. | 04-29-2010 |
| 20100216714 | NATRIURETIC COMPOUNDS, CONJUGATES, AND USES THEREOF - Modified natriuretic compounds and conjugates thereof are disclosed in the present invention. In particular, conjugated forms of hBNP are provided that include at least one modifying moiety attached thereto. The modified natriuretic compound conjugates retain activity for stimulating cGMP production, binding to NPR-A receptor, and in some embodiments an improved half-life in circulation as compared to unmodified counterpart natriuretic compounds. Oral, parenteral, enteral, subcutaneous, pulmonary, and intravenous forms of the compounds and conjugates may be prepared as treatments and/or therapies for heart conditions particularly congestive heart failure. Modifying moieties comprising oligomeric structures having a variety of lengths and configurations are also disclosed. Analogs of the natriuretic compound are also disclosed, having an amino acid sequence that is other than the native sequence. | 08-26-2010 |
| 20110118179 | CATION COMPLEXES OF INSULIN COMPOUND CONJUGATES, FORMULATIONS AND USES THEREOF - An insulin compound coupled to a modifying moiety having a formula: | 05-19-2011 |
| 20110124553 | INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOF - An insulin compound coupled to a modifying moiety having a formula: | 05-26-2011 |
| Patent application number | Description | Published |
|---|
| 20100005898 | System and method for conditioning and detection of moisture damage in asphalt mixes - An apparatus and method for determination of susceptibility of asphalt concrete materials to moisture damage. An asphalt sample of known bulk specific gravity (density) is placed inside a chamber filled with water, which is capable of heating the sample to a pre-determined temperature. The chamber is pressurized by introduction of air pressure to a flexible membrane that decreases the volume within a chamber containing the sample and water, increasing the pore pressure in the sample. The pressure is then released and allowed to come to ambient pressure. This process is repeated a predetermined number of times (cycles). When a selected number of cycles are complete, the asphalt sample is removed from the chamber and its bulk specific gravity (density) measured again. The difference between the density before and after conditioning is an excellent method of rating the degree at which moisture would deteriorate asphalt samples due to introduction of moisture. The cyclic nature of the increased/decreased pore pressure is observed to significantly decrease bulk specific gravity (density) for poor quality asphalt designs. Furthermore, the sample conditioned by this method can be used for other conventional mechanical test methods, such as tensile strength and modulus determination. Computerized controls are used to automate the procedure and to record and display data from sensors. | 01-14-2010 |
| 20100319211 | Device and Methods for Rapid Drying of Porous Materials - An apparatus and method for quickly drying porous materials. A sealable chamber is connected to a cold trap which is connected to a vacuum pump. A sample is placed inside the sealable chamber. The vacuum pump is turned on and air is evacuated through the cold trap to the vacuum pump. Because evaporation may lower the temperature inside the sealable chamber, an infrared lamp may be used to heat the chamber and sample therein directly or heated air may be allowed to enter the sealable chamber in response to the vacuum created by the vacuum pump. Air may be drawn directly from the sealable chamber to the vacuum pump bypassing the cold trap. A load cell may be placed in the bottom of the sealable chamber to monitor the weight of a sample to determine if the drying process is complete. Other parameters could be used, including the degree of vacuum achieved in the chamber. The cold trap extracts moisture from the system, which eliminates the possibility of damage to the vacuum and creates an added pressure gradient for removal of air from the sealable chamber. Heating the chamber either by introducing heated air or by direct use of infrared heat facilitates drying of the sample and shortens the drying process. | 12-23-2010 |
| 20110214484 | System and Method for Conditioning and Detection of Susceptibility to Moisture Damage in Asphalt Mixes - An apparatus and method for determination of susceptibility of asphalt concrete materials to moisture damage. An asphalt sample of known bulk specific gravity (density) is placed inside a chamber filled with water, which is capable of heating the sample to a predetermined temperature. The chamber is pressurized by introduction of air pressure to a flexible membrane that decreases the volume within a chamber containing the sample and water, increasing the pore pressure in the sample. The pressure is then released and allowed to come to ambient pressure. This process is repeated a predetermined number of times (cycles). When a selected number of cycles are complete, the asphalt sample is removed from the chamber and its bulk specific gravity (density) measured again. The difference between the density before and after conditioning is an excellent method of rating the degree at which moisture would deteriorate asphalt samples due to introduction of moisture. The cyclic nature of the increased/decreased pore pressure is observed to significantly decrease bulk specific gravity (density) for poor quality asphalt designs. Furthermore, the sample conditioned by this method can be used for other conventional mechanical test methods, such as tensile strength and modulus determination. Computerized controls are used to automate the procedure and to record and display data from sensors. | 09-08-2011 |
| Patent application number | Description | Published |
|---|
| 20090122946 | Rod assembly for nuclear reactors - A rod assembly for a fuel bundle of a nuclear reactor may include an upper end piece, lower end piece and a plurality of rod segments attached between the upper and lower end pieces and to each other so as to form an axial length of the rod assembly. The rod assembly may include an adaptor subassembly provided at given connection points for connecting adjacent rod segments or a given rod segment with one of the upper and lower end pieces. The connection points along the axial length of the rod assembly may be located where the rod assembly contacts a spacer in the fuel bundle. One (or more) of the rod segments may include an irradiation target therein for producing a desired isotope when a fuel bundle containing one (or more) rod assemblies is irradiated in a core of the reactor. | 05-14-2009 |
| 20090135988 | Fail-Free Fuel Bundle Assembly - A fuel bundle for a nuclear reactor core is provided. The fuel bundle may include a plurality of rods comprised of nuclear fuel rods and/or isotope production rods. Each rod includes a plurality of interconnected rod segments, wherein at least two of the rod segments of at least one rod have different outside diameters. The fuel bundle may additionally include a plurality of rod spacer grids securely retained between axially adjacent, interconnected rod segments. The rod spacer grids interconnected between axially adjacent rod segments form an array of substantially equally spaced rods. The fuel bundle may further include an elongate tubular channel in which the arrayed rods are housed. | 05-28-2009 |
| 20090135989 | Segmented fuel rod bundle designs using fixed spacer plates - Example embodiments are directed to a fuel rod design using segmented fuel rods that mechanically confine spacer plates to constant axial positions. Example embodiment spacer plates may be placed at axial connection points between fuel rod segments, and, when the fuel rod segments are mated, example embodiment spacer plates may be mechanically held by the mating. | 05-28-2009 |
| 20100030008 | Segmented waste rods for handling nuclear waste and methods of using and fabricating the same - Example embodiments and methods may provide segmented waste rods capable of containing and disposing of waste generated from spent nuclear fuel, including elements left over from fuel that has been harvested for desired isotopes produced in the fuel. Example methods may provide methods for forming and using example embodiment segmented waste rods. | 02-04-2010 |
